Guardion Health Sciences Inc (GHSI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
3.2200 -0.0700 (-2.13%) 10/30/24 [OTC US]
N/A x N/A N/A x N/A
Post-market 3.2200 unch (unch) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 158 | -14,922 | -24,745 | -8,572 | -10,878 |
| Depreciation Amortization | 19 | 11,315 | 12,676 | 220 | 2,439 |
| Accounts receivable | -352 | -94 | 379 | 67 | -50 |
| Accounts payable and accrued liabilities | -904 | 1,277 | N/A | N/A | N/A |
| Other Working Capital | -573 | -1,893 | -312 | -299 | -433 |
| Other Operating Activity | -2,718 | -3,129 | 1,358 | 570 | 2,892 |
| Operating Cash Flow | $-4,370 | $-7,447 | $-10,644 | $-8,014 | $-6,030 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -6 | -75 | -41 | -171 |
| Net Acquisitions | 20 | N/A | -25,941 | 6 | N/A |
| Purchase Of Investment | N/A | -77,592 | -70,953 | N/A | N/A |
| Sale Of Investment | N/A | 82,587 | 65,957 | N/A | N/A |
| Investing Cash Flow | $16 | $4,990 | $-31,011 | $-35 | $-171 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 350 |
| Debt Repayment | N/A | N/A | N/A | N/A | -101 |
| Common Stock Issued | 58 | 9,969 | 37,231 | 5,452 | 16,396 |
| Common Stock Repurchased | N/A | -9 | N/A | N/A | N/A |
| Other Financing Activity | -5,250 | 4,308 | 0 | 0 | 0 |
| Financing Cash Flow | $-5,192 | $14,268 | $37,231 | $5,452 | $16,646 |
| Beginning Cash Position | 15,906 | 4,094 | 8,519 | 11,116 | 671 |
| End Cash Position | 6,360 | 15,906 | 4,094 | 8,519 | 11,116 |
| Net Cash Flow | $-9,546 | $11,812 | $-4,425 | $-2,597 | $10,445 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,370 | -7,447 | -10,644 | -8,014 | -6,030 |
| Capital Expenditure | -4 | -6 | -75 | -41 | -171 |
| Free Cash Flow | -4,374 | -7,452 | -10,719 | -8,055 | -6,201 |